betway必威登陆网址 (betway.com )学报 ›› 2021, Vol. 42 ›› Issue (1): 31-36.DOI: 10.3969/j.issn.1004-7115.2021.01.008

• 论著 • 上一篇    下一篇

围产期心肌病的预后影响因素

亓西美, 杜洋, 张萍萍, 王冬梅, 杜波   

  1. 泰安市中心医院心内科,山东 泰安 271000
  • 收稿日期:2020-09-12 发布日期:2021-09-01
  • 通讯作者: 杜波,主任医师,硕士,研究方向:心肺血管疾病。
  • 作者简介:亓西美,主治医师,硕士,主要从事心血管疾病的临床诊治工作,E-mail:qxm19840415@126.com。
  • 基金资助:
    泰安市科技发展计划(2019NS201)。

Analysis of prognostic factors of perinatal cardiomyopathy

QI Xi-mei, DU Yang, ZHANG Ping-ping, WANG Dong-mei, DU Bo   

  1. Taian Central Hospital, Taian 271000, China
  • Received:2020-09-12 Published:2021-09-01

摘要: 目的 通过研究围产期心肌病的临床特点,为围产期心肌病的诊断和治疗提供参考依据。方法 回顾性分析2008年1月至2019年5月间,在我院诊断为围产期心肌病共34例住院患者的临床资料、检查结果、诊治过程、疾病转归及随访1~114个月的记录。根据复查左室舒张末内径(left ventricular end diastolic diameter,LVED)是否恢复正常(≤50 mm)、左心室射血分数(left ventricular ejection fraction,LVEF)是否恢复正常(≥50%),将患者分为治愈组和未愈组。其中23例(68%)患者治愈为治愈组,年龄(30.6±7.2)岁,体重指数(29.0±2.1) kg/m2,首次诊断时LVEF为(40.2±9.2)%,LVED为(58.0±6.5)mm;11例(32%)患者未治愈为未愈组,年龄(34.2±5.6)岁,体重指数(35.6±1.9) kg/m2,首次诊断时LVEF为(30.9±10.2)%,LVED为(65.0±6.3)mm。比较两组的临床特点、辅助检查结果、治疗方案及转归情况。结果 治愈组与未愈组在既往史、年龄、发病时间(孕期或剖宫产术后)、术后发病时间、血压、心率、血红蛋白、血糖、C反应蛋白、促甲状腺激素、肌酸激酶、肌酸激酶同工酶、N端脑钠肽前体(NT-proBNP) 、尿酸、肺动脉压、应用血管紧张素转化酶抑制剂(ACEI)或血管紧张素II受体拮抗剂(ARB)、β受体阻滞剂、地高辛方面差异均无统计学意义(P>0.05),治愈组较未愈组体重指数低(t=8.940,P<0.001)、胎次(P<0.001)及胎数(P<0.001)少,肌钙蛋白高(Z=2.024,P=0.043)、尿蛋白少(P=0.002),左室舒张末内径偏小(t=2.965,P=0.006),LVEF偏高(t=2.633,P=0.012),二尖瓣返流(P<0.001)、胸腔积液(P<0.001)程度轻,应用溴隐亭比例高(P<0.001)。结论 肥胖、多胎孕妇、经产妇、肌钙蛋白、尿蛋白、左室舒张末内径、LVEF、二尖瓣返流、胸腔积液、应用溴隐亭治疗是疾病转归的影响因素,其中左室舒张末内径≥63 mm提示预后欠佳。

关键词: 围产期心肌病, 预后影响, 左室舒张末内径

Abstract: Objective: To determine predictors and indicators of clinical outcomes of patients with peripartum cardiomyopathy (PPCM).Methods: The retrospective study was conducted from January 2008 to May 2019 at our Hospital. Forty-four cases were collected and followed up for 1-114 months. Recovery was defined as a left ventricular end diastolic diameter (LVEDD) of no more than 50 mm and a left ventricular ejection fraction(LVEF) of no less than 50% . Persistent left ventricular dysfunction was defined as a LVEDD of more than 50mm and LVEF of less than 50% at the end of follow-up.The clinical characteristics, treatment protocols and outcomes of the patients were compared.Results: In this study, the estimated incidence of PPCM was approximately 1/1 710,44 cases were collected and followed up for 1-114 months. 34 of all the patients completed the follow-up.23 (68%) cases recovered and 11(32%) did not. The average age of 23 (68%) was (30.6±7.2) years old. Their body mass index (BMI) was (29.0±2.1)kg/m2. The LVEF at diagnosis was (40.02±9.2)%, and the LVEDD was (58.0±6.5)mm. The average age of 11 (32%) was (34.2±5.6) years old. Their body mass index (BMI) was (35.6±1.9)kg/m2. The LVEF at diagnosis was (30.9±10.2)%, and the LVEDD was (65.0±6.3)mm. (2) There was no significant difference in the past history, age, onset time, blood pressure, heart rate, hemoglobin, glucose, C reactive protein (CRP), thyroid stimulating hormone(TSH), creatine kinase (CK), creatine kinase isoenzymes (CKMB), NT-proBNP uric acid, pulmonary aterial systolic pressure (PASP) and the percentage of patients taking ACEI or ARB, β-blockers and Digoxin between the two groups (P>0.05). Compared with the control group,the recovery group had lower BMI(t=8.940,P<0.001),lesser parities(P<0.001), lesser number of fetus(P<0.001),higher cardiac troponins(Z=2.024,P=0.043), lesser proteinuria (P=0.002), smaller left ventricular (t=2.965,P=0.006),. higher left ventricular ejection fraction(t=2.633,P=0.012), lesser severity of mitral regurgitation(P<0.001)and pleural effusions(P<0.001)and higher bromocriptine(P<0.001).Conclusion: High body mass index, multiparity, multiple pregnancy, left ventricular end diastolic diameter left ventricular ejection fraction severity of mitral regurgitation and the use of beta blockers or bromocriptine are all indicators of prognosis of patients with PPCM, among which left ventricular end diastolic diameter of being more than or equal to 63mm indicates poor prognosis.

Key words: peripartum cardiomyopathy, prognosis, left ventricular end diastolic diameter

中图分类号: